Cargando…
The origin of cost–benefit analysis: a comparative view of France and the United States
BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600932/ https://www.ncbi.nlm.nih.gov/pubmed/34794465 http://dx.doi.org/10.1186/s12962-021-00330-3 |
_version_ | 1784601249617805312 |
---|---|
author | Jiang, Wei Marggraf, Rainer |
author_facet | Jiang, Wei Marggraf, Rainer |
author_sort | Jiang, Wei |
collection | PubMed |
description | BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been subject to neglect. We attempt to fill this gap and clarify the origin and the early development of CBA. METHODS: A comparative analysis is used to investigate the origin and the early development of CBA in France and the USA. The comparison is focused on two questions: (1) which criteria should be applied to decide whether or not a project should be carried out, and (2) with which procedure these criteria can be used for real projects. RESULTS: The origin of CBA can be dated back to the work of Saint-Pierre in France in 1708. Dupuit introduces the concept of consumer’s surplus that founds the economic basis of CBA. These works are not taken seriously in France and do not draw attention from other countries. Hence, until the 1930s, the principle of CBA is newly proposed in the US and the Green Book marks the mature of CBA. CONCLUSIONS: The early development of CBA in France and the US is independent from the aspects of historical background, personnel, approaches and standardization. This study could help researchers of various disciplines be sure about the history of CBA when they perform this analysis in their research areas. |
format | Online Article Text |
id | pubmed-8600932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86009322021-11-19 The origin of cost–benefit analysis: a comparative view of France and the United States Jiang, Wei Marggraf, Rainer Cost Eff Resour Alloc Research BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been subject to neglect. We attempt to fill this gap and clarify the origin and the early development of CBA. METHODS: A comparative analysis is used to investigate the origin and the early development of CBA in France and the USA. The comparison is focused on two questions: (1) which criteria should be applied to decide whether or not a project should be carried out, and (2) with which procedure these criteria can be used for real projects. RESULTS: The origin of CBA can be dated back to the work of Saint-Pierre in France in 1708. Dupuit introduces the concept of consumer’s surplus that founds the economic basis of CBA. These works are not taken seriously in France and do not draw attention from other countries. Hence, until the 1930s, the principle of CBA is newly proposed in the US and the Green Book marks the mature of CBA. CONCLUSIONS: The early development of CBA in France and the US is independent from the aspects of historical background, personnel, approaches and standardization. This study could help researchers of various disciplines be sure about the history of CBA when they perform this analysis in their research areas. BioMed Central 2021-11-18 /pmc/articles/PMC8600932/ /pubmed/34794465 http://dx.doi.org/10.1186/s12962-021-00330-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jiang, Wei Marggraf, Rainer The origin of cost–benefit analysis: a comparative view of France and the United States |
title | The origin of cost–benefit analysis: a comparative view of France and the United States |
title_full | The origin of cost–benefit analysis: a comparative view of France and the United States |
title_fullStr | The origin of cost–benefit analysis: a comparative view of France and the United States |
title_full_unstemmed | The origin of cost–benefit analysis: a comparative view of France and the United States |
title_short | The origin of cost–benefit analysis: a comparative view of France and the United States |
title_sort | origin of cost–benefit analysis: a comparative view of france and the united states |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600932/ https://www.ncbi.nlm.nih.gov/pubmed/34794465 http://dx.doi.org/10.1186/s12962-021-00330-3 |
work_keys_str_mv | AT jiangwei theoriginofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates AT marggrafrainer theoriginofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates AT jiangwei originofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates AT marggrafrainer originofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates |